Emerging research into blood tests for breast cancer biomarkers presents a potential breakthrough in non-invasive cancer detection. These tests, often referred to as “liquid biopsies,” look for DNA fragments shed by tumors into the bloodstream. Early results are encouraging, suggesting these tests could complement existing screening methods by identifying cancers that are difficult to detect through imaging, thus playing a crucial role in early detection strategies.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.